购物车
- 全部删除
- 您的购物车当前为空
EGFR-IN-117(Compound 8h)能够对EGFR突变进行靶向抑制,并诱导癌细胞凋亡(apoptosis)。该化合物在H1975、PC-9 以及变异细胞BaF3-EGFRL858R/T790M/C797S和BaF3–C797S/Del19/T790M中表现出显著的抑制活性,其IC50值分别为13 nM、19 nM、1.2 nM和1.3 nM。此外,EGFR-IN-117在小鼠模型上也展现了其抗肿瘤效果。
EGFR-IN-117(Compound 8h)能够对EGFR突变进行靶向抑制,并诱导癌细胞凋亡(apoptosis)。该化合物在H1975、PC-9 以及变异细胞BaF3-EGFRL858R/T790M/C797S和BaF3–C797S/Del19/T790M中表现出显著的抑制活性,其IC50值分别为13 nM、19 nM、1.2 nM和1.3 nM。此外,EGFR-IN-117在小鼠模型上也展现了其抗肿瘤效果。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | EGFR-IN-117 (Compound 8h) exhibits inhibitory activity against EGFR mutations, specifically targeting the tumor environment and inducing apoptosis in cancer cells. This compound effectively inhibits the proliferation of H1975, PC-9, and mutant EGFR cells including BaF3-EGFRL858R/T790M/C797S and BaF3–C797S/Del19/T790M, with IC50 values of 13 nM, 19 nM, 1.2 nM, and 1.3 nM respectively. Additionally, EGFR-IN-117 demonstrates anti-tumor activity in mouse models. |
分子量 | 572.52 |
分子式 | C25H30BrN7O2S |
CAS No. | 3035639-05-2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容